Literature DB >> 22197090

Diffusion weighted MRI and 18F-FDG PET/CT in non-small cell lung cancer (NSCLC): does the apparent diffusion coefficient (ADC) correlate with tracer uptake (SUV)?

M Regier1, T Derlin, D Schwarz, A Laqmani, F O Henes, M Groth, J-H Buhk, H Kooijman, G Adam.   

Abstract

INTRODUCTION: To investigate the potential correlation of the apparent diffusion coefficient assessed by diffusion-weighted MRI (DWI) and glucose metabolism determined by the standardized uptake value (SUV) at 18F-FDG PET/CT in non-small cell lung cancer (NSCLC).
MATERIALS AND METHODS: 18F-FDG PET/CT and DWI (TR/TE, 2000/66 ms; b-values, 0 and 500 s/mm(2)) were performed in 41 consecutive patients with histologically verified NSCLC. Analysing the PET-CT data calculation of the mean (SUV(mean)) and maximum (SUV(max)) SUV was performed. By placing a region-of-interest (ROI) encovering the entire tumor mean (ADC(mean)) and minimum ADC (ADC(min)) were determined by two independent radiologists. Results of 18F-FDG PET-CT and DWI were compared on a per-patient basis. For statistical analysis Pearson's correlation coefficient, Bland-Altman and regression analysis were assessed.
RESULTS: Data analysis revealed a significant inverse correlation of the ADC(min) and SUV(max) (r=-0.46; p=0.032). Testing the correlation of the ADC(min) and SUV(max) for each histological subtype separately revealed that the inverse correlation was good for both adenocarcinomas (r=-0.47; p=0.03) and squamouscell carcinomas (r=-0.71; p=0.002), respectively. No significant correlation was found for the comparison of ADC(min) and SUV(mean) (r=-0.29; p=0.27), ADC(mean) vs. SUV(mean) (r=-0.28; p=0.31) or ADC(mean) vs. SUV(max) (r=-0.33; p=0.23). The κ-value of 0.88 indicated a good agreement between both observers.
CONCLUSION: This preliminary study is the first to verify the relation between the SUV and the ADC in NSCLC. The significant inverse correlation of these two quantitative imaging approaches points out the association of metabolic activity and tumor cellularity. Therefore, DWI with ADC measurement might represent a new prognostic marker in NSCLC.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22197090     DOI: 10.1016/j.ejrad.2011.11.050

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  25 in total

Review 1.  Magnetic resonance imaging in lung: a review of its potential for radiotherapy.

Authors:  Shivani Kumar; Gary Liney; Robba Rai; Lois Holloway; Daniel Moses; Shalini K Vinod
Journal:  Br J Radiol       Date:  2016-02-03       Impact factor: 3.039

2.  Thoracic staging of non-small-cell lung cancer using integrated (18)F-FDG PET/MR imaging: diagnostic value of different MR sequences.

Authors:  Benedikt Schaarschmidt; Christian Buchbender; Benedikt Gomez; Christian Rubbert; Florian Hild; Jens Köhler; Johannes Grueneisen; Henning Reis; Verena Ruhlmann; Axel Wetter; Harald H Quick; Gerald Antoch; Philipp Heusch
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-04-08       Impact factor: 9.236

3.  Multiparametric voxel-based analyses of standardized uptake values and apparent diffusion coefficients of soft-tissue tumours with a positron emission tomography/magnetic resonance system: Preliminary results.

Authors:  Koji Sagiyama; Yuji Watanabe; Ryotaro Kamei; Sungtak Hong; Satoshi Kawanami; Yoshihiro Matsumoto; Hiroshi Honda
Journal:  Eur Radiol       Date:  2017-06-20       Impact factor: 5.315

Review 4.  Advances in Imaging and Automated Quantification of Malignant Pulmonary Diseases: A State-of-the-Art Review.

Authors:  Bruno Hochhegger; Matheus Zanon; Stephan Altmayer; Gabriel S Pacini; Fernanda Balbinot; Martina Z Francisco; Ruhana Dalla Costa; Guilherme Watte; Marcel Koenigkam Santos; Marcelo C Barros; Diana Penha; Klaus Irion; Edson Marchiori
Journal:  Lung       Date:  2018-10-09       Impact factor: 2.584

5.  PET/MRI for the evaluation of patients with lymphoma: initial observations.

Authors:  Laura Heacock; Joseph Weissbrot; Roy Raad; Naomi Campbell; Kent P Friedman; Fabio Ponzo; Hersh Chandarana
Journal:  AJR Am J Roentgenol       Date:  2015-04       Impact factor: 3.959

Review 6.  Validation of functional imaging as a biomarker for radiation treatment response.

Authors:  C Jentsch; B Beuthien-Baumann; E G C Troost; G Shakirin
Journal:  Br J Radiol       Date:  2015-05-29       Impact factor: 3.039

7.  Diffusion-weighted (DW) MRI in lung cancers: ADC test-retest repeatability.

Authors:  Alex Weller; Marianthi Vasiliki Papoutsaki; John C Waterton; Arturo Chiti; Sigrid Stroobants; Joost Kuijer; Matthew Blackledge; Veronica Morgan; Nandita M deSouza
Journal:  Eur Radiol       Date:  2017-04-10       Impact factor: 5.315

8.  Functional imaging of head and neck squamous cell carcinoma with diffusion-weighted MRI and FDG PET/CT: quantitative analysis of ADC and SUV.

Authors:  Arthur Varoquaux; Olivier Rager; Karl-Olof Lovblad; Karen Masterson; Pavel Dulguerov; Osman Ratib; Christoph D Becker; Minerva Becker
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-02-22       Impact factor: 9.236

9.  Multiparametric MR and PET Imaging of Intratumoral Biological Heterogeneity in Patients with Metastatic Lung Cancer Using Voxel-by-Voxel Analysis.

Authors:  Stephan Metz; Carl Ganter; Sylvie Lorenzen; Sandra van Marwick; Konstantin Holzapfel; Ken Herrmann; Ernst J Rummeny; Hans-Jürgen Wester; Markus Schwaiger; Stephan G Nekolla; Ambros J Beer
Journal:  PLoS One       Date:  2015-07-17       Impact factor: 3.240

Review 10.  Diffusion magnetic resonance imaging of chest tumors.

Authors:  A A K Abdel Razek
Journal:  Cancer Imaging       Date:  2012-10-26       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.